The “Aa2” rating is based on numerous factors, including Mayo’s large size, demonstrated national and international draw for patients and strong fundraising ability.
Offsetting these strengths is Mayo Clinic’s support of research and education activities that suppress adjusted margins.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that Mayo will continue to generate adequate adjusted operating margins and sustain liquidity ratios.
More articles on healthcare finance:
RCM startup insider: MedPilot
Proposal to fund Okla. Medicaid program with cigarette tax gets backing from healthcare groups
Ascension to issue $1.34B in bonds to refinance Ministry hospitals
